✦ LIBER ✦

Topotecan (T) as second-line therapy following ifosfamide-carboplatin-etoposide (ICE) and maintenance for small cell lung cancer (SCLC)

✍ Scribed by Ruotsalainen, T; Mattson, K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide (VP-16) and carboplatin as a f

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Phase I trial of topotecan (T) carboplat

✍ Gillenwater, H.H; McCune, J.S; Donahue, A.E; Faucette, S.R; Shifflett, S; Lindle 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Cis-platin and etoposide (D-V) as second

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 177 KB

P-57 High-dose ifosfamide, carboplatin a

✍ Katakami, Nobuyuki; Kinose, Daisuke; Ikeda, Akihiko; Yoshioka, Hiroshige; Hayash 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

41 Preliminary results of a randomized c

✍ Schiller, J.H.; von Pawel, J.; Clarke, P.; Kleisbauer, J.P.; Dobbs, T.; Chrysson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Phase-II trial of Etoposide (E) and Carb

✍ Garfield, D.; Dakhil, S.; Abubakr, Y.; Kruger, S.; Frank, S. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 86 KB